JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB124763

重组Anti-RAP80抗体[EPR5315]

Anti-RAP80 antibody [EPR5315]

3

(1 Review)

|

(6 Publications)

Rabbit Recombinant Monoclonal RAP80 antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 6 publications.

查看别名

RAP80, RXRIP110, UIMC1, BRCA1-A complex subunit RAP80, Receptor-associated protein 80, Retinoid X receptor-interacting protein 110, Ubiquitin interaction motif-containing protein 1

3 Images
Western blot - Anti-RAP80 antibody [EPR5315] (AB124763)
  • WB

Unknown

Western blot - Anti-RAP80 antibody [EPR5315] (AB124763)

All lanes:

Western blot - Anti-RAP80 antibody [EPR5315] (ab124763) at 1/10000 dilution

Lane 1:

HeLa cell lysate at 10 µg

Lane 2:

Human ovary cancer lysate at 10 µg

Lane 3:

293T cell lysate at 10 µg

Lane 4:

HT-1080 cell lysate at 10 µg

Secondary

All lanes:

Goat anti-Rabbit HRP at 1/2000 dilution

Predicted band size: 80 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RAP80 antibody [EPR5315] (AB124763)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RAP80 antibody [EPR5315] (AB124763)

ab124763 at 1/250 staining RAP80 in paraffin-embedded Human testis tissue by Immunohistochemistry.

Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Western blot - Anti-RAP80 antibody [EPR5315] (AB124763)
  • WB

CiteAb

Western blot - Anti-RAP80 antibody [EPR5315] (AB124763)

RAP80 western blot using anti-RAP80 antibody [EPR5315] ab124763. Publication image and figure legend from Renaud, E., Barascu, A., et al., 2016, Nucleic Acids Res, PubMed 26446986.

ab124763 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab124763 please see the product overview.

53BP1 and RAP80 altered foci accumulation in FA pathway-deficient cells. (A) Representative images of RAP80 (red) and 53BP1 (green) foci in nuclei (DAPI stained, blue) of FANCC-mutated (PD331 FANCC-/-) and -corrected (PD331corr) cells 24 h after MMC exposure (1 μg/ml/1 h). White line : 2 μm. (B) Representative images of RIF1 (red) and 53BP1 (green) foci in nuclei (DAPI stained, blue) of FANCC-mutated (PD331 FANCC-/-) and -corrected (PD331corr) cells 24 hours after MMC exposure (1 μg/ml/1 h). White line : 2 μm. (C) 53BP1 and RAP80 foci quantificationin untreatyed cells (0 h) and at different time points (1, 6 and 24 h) following MMC exposure (1 μg/ml/1 h). Histograms represent the mean of three independent experiments. Error bars indicate S.D. The data were analyzed by a Student's t-test; ** indicates p < 0.01. (D) Size (arbitrary unit, a.u.) of 53BP1 foci in untreated conditions and 24 h after MMC exposure (1 μg/ml/1 h) in FANCC-mutated (PD331 FANCC-/-) and -corrected (PD331corr) cells. The cell size was determined using the ImageJ software. The values on the histogram represent the mean of three independent experiments; at least 50 cells were scored each time. Error bars indicate S.D. Data were analyzed by a Student's t-test; *** indicates p < 0.001. (E) Western blot showing the efficiency of the siRNA against 53BP1 and RAP80, as observed 72 h after transfection, in corrected (PD331 corr) and FA-C (PD331 FANCC-/-) cells. Vinculin was used as a loading control. siCtrl (control) indicates cells transfected with an untargeted siRNA. (F) Representative images of RAP80 (red) and 53BP1 (green) foci in nuclei (DAPI stained, blue) of FANCC-corrected cells (PD331 corr) after depletion of 53BP1 or RAP80 by siRNA transfection. Cells were treated with MMC (1 μg/ml/1 h) and analyzed 24 h later. White line : 2 μm. siCtrl (control) indicates cells transfected with an untargeted siRNA. (G) Quantification of RAP80 foci-positive cells after transfection with an untargeted siRNA (siCtrl, control), si53BP1 or siMDC1 in FANCC-mutated (PD331 FANCC-/-) and -corrected (PD331corr). Cells presenting more than 5 foci were considered positive. Data represent the mean of two independent experiments with similar results. (H) Left. Representative images of BRCA1/RAP80 interaction dots detected with the Proximity Ligation Assay in nuclei (DAPI stained, blue) in FANCC-mutated (PD331 FANCC-/-) and -corrected (PD331corr) cells under untreated conditions or 24 h following MMC exposure (1 μg/ml/1 h). White line : 8 μm. Right. BRCA1/RAP80 interaction dots quantification 24 h after MMC exposure (1 μg/ml/1 h). Histograms represent the pooled data from three independent experiments. Quantification was conducted using ImageJ software. (I) Left. Representative images of BRCA1/CtIP (left) interaction dots detected with the Proximity Ligation Assay in nuclei (DAPI stained, blue) in FANCC-mutated (PD331 FANCC-/-) and -corrected (PD331corr) cells under untreated conditions or 24 hours following MMC exposure (1 μg/ml/1 h). White line : 8 μm. Right. BRCA1/CtIP interaction dots quantification 24 h after MMC exposure (1 μg/ml/1 h). Histograms represent the pooled data from three independent experiments. Quantification was conducted using ImageJ software. (J) Representative images of FANCD2 foci (red), RAP80 (red) or 53BP1 (green) in PD20 corr (FANCD2-corrected cells), PD20 (FANCD2-/- cells) and PD20 FANCD2 K561R (PD20 cells expressing a K561R, non-ubiquitinable FANCD2) cells. White line : 2 μm. Histograms represent the number of RAP80 (red) and 53BP1 (green) foci in the three different cell lines in the left. Data represent the mean of two independent experiments with similar results.

false

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

EPR5315

亚型

IgG

不含载体蛋白

No

反应种属

Human

应用

WB, IHC-P

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/250 - 1/500", "IHCP-species-notes": "<p>Heat up to 98 degrees C, below boiling, and then let cool for 10-20 min.</p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000 - 1/50000", "WB-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/250 - 1/500", "IHCP-species-notes": "<p>Heat up to 98 degrees C, below boiling, and then let cool for 10-20 min.</p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/10000 - 1/50000", "WB-species-notes": "<p></p>" }, "Rat": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/250 - 1/500", "IHCP-species-notes": "<p>Heat up to 98 degrees C, below boiling, and then let cool for 10-20 min.</p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/10000 - 1/50000", "WB-species-notes": "<p></p>" } } }

产品详情

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
pH: 7.2 - 7.4 Preservative: 0.05% Sodium azide Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9.85% Tris glycine, 0.1% BSA
运输条件
Blue Ice
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
储存信息
Stable for 12 months at -20°C

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Ubiquitin-binding protein (PubMed : 24627472). Specifically recognizes and binds 'Lys-63'-linked ubiquitin (PubMed : 19328070, Ref.38). Plays a central role in the BRCA1-A complex by specifically binding 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA lesions sites, leading to target the BRCA1-BARD1 heterodimer to sites of DNA damage at double-strand breaks (DSBs). The BRCA1-A complex also possesses deubiquitinase activity that specifically removes 'Lys-63'-linked ubiquitin on histones H2A and H2AX. Also weakly binds monoubiquitin but with much less affinity than 'Lys-63'-linked ubiquitin. May interact with monoubiquitinated histones H2A and H2B; the relevance of such results is however unclear in vivo. Does not bind Lys-48'-linked ubiquitin. May indirectly act as a transcriptional repressor by inhibiting the interaction of NR6A1 with the corepressor NCOR1.
See full target information UIMC1

文献 (6)

Recent publications for all applications. Explore the full list and refine your search

Science signaling 11: PubMed29871913

2018

K63-linked polyubiquitin chains bind to DNA to facilitate DNA damage repair.

Applications

Unspecified application

Species

Unspecified reactive species

Pengda Liu,Wenjian Gan,Siyuan Su,Arthur V Hauenstein,Tian-Min Fu,Bradley Brasher,Carsten Schwerdtfeger,Anthony C Liang,Ming Xu,Wenyi Wei

Cell death and differentiation 23:1406-16 PubMed27035619

2016

NRAGE is involved in homologous recombination repair to resist the DNA-damaging chemotherapy and composes a ternary complex with RNF8-BARD1 to promote cell survival in squamous esophageal tumorigenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Q Yang,Q Pan,C Li,Y Xu,C Wen,F Sun

Oncotarget 7:8956-67 PubMed26788910

2016

Adenovirus-mediated downregulation of the ubiquitin ligase RNF8 sensitizes bladder cancer to radiotherapy.

Applications

IF

Species

Unspecified reactive species

Mei-Jun Zhao,Yan-Feng Song,Hai-Tao Niu,Ying-Xia Tian,Xu-Guang Yang,Kun Xie,Yu-Hong Jing,De-Gui Wang

Nucleic acids research 44:648-56 PubMed26446986

2015

Impaired TIP60-mediated H4K16 acetylation accounts for the aberrant chromatin accumulation of 53BP1 and RAP80 in Fanconi anemia pathway-deficient cells.

Applications

WB

Species

Human

Emilie Renaud,Aurelia Barascu,Filippo Rosselli

Nucleic acids research 42:5582-93 PubMed24711370

2014

HSCARG, a novel regulator of H2A ubiquitination by downregulating PRC1 ubiquitin E3 ligase activity, is essential for cell proliferation.

Applications

Unspecified application

Species

Human

Bin Hu,Shangze Li,Xiaodong Zhang,Xiaofeng Zheng

Nucleic acids research 41:10298-311 PubMed24013561

2013

Co-operation of BRCA1 and POH1 relieves the barriers posed by 53BP1 and RAP80 to resection.

Applications

ICC/IF

Species

Unspecified reactive species

Andreas Kakarougkas,Amani Ismail,Yoko Katsuki,Raimundo Freire,Atsushi Shibata,Penny A Jeggo
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com